ATE256147T1 - Peptide gegen pilzen - Google Patents

Peptide gegen pilzen

Info

Publication number
ATE256147T1
ATE256147T1 AT95928105T AT95928105T ATE256147T1 AT E256147 T1 ATE256147 T1 AT E256147T1 AT 95928105 T AT95928105 T AT 95928105T AT 95928105 T AT95928105 T AT 95928105T AT E256147 T1 ATE256147 T1 AT E256147T1
Authority
AT
Austria
Prior art keywords
peptides
amino acids
against fungi
peptides against
wlqlf
Prior art date
Application number
AT95928105T
Other languages
English (en)
Inventor
Roger G Ii Little
Edward Lim
Mitchell B Fadem
Original Assignee
Xoma Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/306,473 external-priority patent/US5652332A/en
Priority claimed from US08/372,105 external-priority patent/US5627153A/en
Application filed by Xoma Technology Ltd filed Critical Xoma Technology Ltd
Application granted granted Critical
Publication of ATE256147T1 publication Critical patent/ATE256147T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4742—Bactericidal/Permeability-increasing protein [BPI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT95928105T 1994-09-15 1995-07-20 Peptide gegen pilzen ATE256147T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/306,473 US5652332A (en) 1993-03-12 1994-09-15 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
US08/372,105 US5627153A (en) 1994-01-14 1995-01-13 Anti-fungal methods and materials
PCT/US1995/009262 WO1996008509A1 (en) 1994-09-15 1995-07-20 Anti-fungal peptides

Publications (1)

Publication Number Publication Date
ATE256147T1 true ATE256147T1 (de) 2003-12-15

Family

ID=26975179

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95928105T ATE256147T1 (de) 1994-09-15 1995-07-20 Peptide gegen pilzen

Country Status (7)

Country Link
EP (1) EP0824547B1 (de)
JP (1) JPH10508576A (de)
AT (1) ATE256147T1 (de)
AU (1) AU709738B2 (de)
CA (1) CA2200069C (de)
DE (1) DE69532302D1 (de)
WO (1) WO1996008509A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652332A (en) * 1993-03-12 1997-07-29 Xoma Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
WO1997004008A1 (en) * 1995-07-20 1997-02-06 Xoma Corporation Anti-fungal peptides
DE69703689T2 (de) 1996-05-10 2001-05-10 Xoma Technology Ltd., Berkeley Therapeutische anwendungen von bpi-protein-produkten zur behandlung von humaner meningococcämia
US5741779A (en) * 1996-05-10 1998-04-21 Xoma Corporation Antithrombotic materials and methods
NZ332954A (en) * 1996-05-23 2000-07-28 Xoma Corp Use of BPI protein products to treat humans with hemorrhage due to trauma
US5888973A (en) 1996-08-09 1999-03-30 Xoma Corporation Anti-chlamydial uses of BPI protein products
US6482796B2 (en) 1996-11-01 2002-11-19 Xoma Corporation Therapeutic uses of N-terminal BPI protein products in ANCA-positive patients
US6093573A (en) * 1997-06-20 2000-07-25 Xoma Three-dimensional structure of bactericidal/permeability-increasing protein (BPI)
US6013631A (en) * 1998-06-19 2000-01-11 Xoma Corporation Bactericidal/permeability-increasing protein (BPI) deletion analogs
AU6163099A (en) * 1998-09-25 2000-04-17 Xoma Technology Ltd. Antifungal and antibacterial peptide
US6242219B1 (en) 1999-03-18 2001-06-05 Xoma (Us) Llc Methods for recombinant peptide production
US6355616B1 (en) * 1999-06-25 2002-03-12 Xoma (Us) Technology Ltd. Derivative compounds derived from or based on bactericidal/permeability-increasing protein
JP4554370B2 (ja) 2002-03-29 2010-09-29 ゾーマ テクノロジー リミテッド 多重遺伝子プラスミドおよび組み換えポリペプチドの発現増加法
GB201319621D0 (en) 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Antimicrobial agents and their use in therapy
GB201319620D0 (en) 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Immunosuppressive agents and their use in therapy
CN120695260B (zh) * 2025-08-21 2025-11-18 温州医科大学附属口腔医院 一种口腔修复材料改性用涂层、应用及口腔修复材料

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08509703A (ja) * 1993-03-12 1996-10-15 ゾーマ コーポレイション 殺菌／透過性増加タンパク質産物の治療用途
ES2123134T3 (es) * 1993-03-12 1999-01-01 Xoma Corp Peptidos biologicamente activos de dominios funcionales de la proteina bactericida aumentadora de la permeabilidad y usos de los mismos.
US5733872A (en) * 1993-03-12 1998-03-31 Xoma Corporation Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
MX9602570A (es) * 1994-01-14 1997-04-30 Xoma Corp Metodos y materiales anti-fungosos.

Also Published As

Publication number Publication date
CA2200069A1 (en) 1996-03-21
AU709738B2 (en) 1999-09-02
EP0824547B1 (de) 2003-12-10
DE69532302D1 (de) 2004-01-22
AU3198195A (en) 1996-03-29
WO1996008509A1 (en) 1996-03-21
JPH10508576A (ja) 1998-08-25
EP0824547A1 (de) 1998-02-25
CA2200069C (en) 2000-09-26

Similar Documents

Publication Publication Date Title
ATE256147T1 (de) Peptide gegen pilzen
ES2563677T3 (es) Composiciones de combinaciones de Neisseria
DE69838143D1 (de) Antimikrobielle peptide
AU4162400A (en) Derivatives of the b or z domain from staphylococcal protein a (spa) interactingwith at least one domain of human factor viii
NO20100324L (no) Fremgangsmate for trinnvis festing av polyetylenglykol (PEG) andeler i serie til et polypeptid
NZ263344A (en) Human bactericidal/permeability increasing (bpi) protein functional domain peptides and their use
DE69526216D1 (de) Antifungaleverfahren und mitteln
ATE213500T1 (de) Antifungizide peptide auf der grundlage von d- aminosäuren enthaltendem histatin
DE60035419D1 (de) Antigene peptide aus neisseria
DE69629075D1 (de) Zyklische Peptide mit fungizider Wirkung
ATE280777T1 (de) Bradykinin-antagonist peptide mit n- substituierten glycinen
ATE193022T1 (de) Heparin-und sulfatid-bindende peptide vom typ 1 der wiederkehrenden sequenzen vom menschlichen thrombospondin
DE69931482D1 (de) Isolierte peptide die aminosäuresequenzen von ny-eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen
ATE435870T1 (de) Aus ll-37 abgeleiteten peptidinhibitoren von toxinen
ATE408685T1 (de) Antimikrobielle peptide, abstammend von ubiquicidin
ATE474589T1 (de) Angiogene peptide und ihre verwendungen
NO20040880L (no) Casein avledete peptider og anvendelser derav i terapi.
WO2003014078A3 (en) Muc7d1 peptides as antifungal and antibacterial agents
ATE357526T1 (de) Modifizierte hcv peptid-impfstoffe
NO20005081D0 (no) Et polypeptid inneholdende aminosyren fra et N-terminalt kolinbindende protein A-truncat, vaksine avledet derfra og anvendelser derav
WO2002030975A3 (en) Antifungal peptides
ATE362769T1 (de) Lineare kationische peptide mit fungizider wirksamkeit
EE200000478A (et) Peptiid, seda kodeeriv geen, diagnostiline reagent ja diagnostiline reaktiivikomplekt ning vaktsiinkasutamiseks riketsioosi ravis
ATE315646T1 (de) Leukocyten-aktivierender faktor
DE60008749D1 (de) Therapeutische peptide aus untersequenzen von bpi

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties